Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Address

9 Rue de Bitbourg

Website

https://www.procapsgroup.com

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - Specialty & Generic

Key Executives

Mr. Kyle P. Bransfield

Director

Mr. Luis Fernando Castro Vergara

Director

Mr. Alberto Eguiguren Correa

Director

Mr. David Yanovich

Director

Mr. Ruben Minski

CEO/Chairman of the Board/Director/Founder

Mr. Patricio Vargas Munoz

CFO

Dr. Camilo Camacho

COO

Mr. Carlos Piocuda Russo

Vice President, Divisional

Ms. Grethel Moreno Romero

Vice President, Divisional

Ms. Marcela Carvajalino Pagano

Vice President, Divisional

Mr. Mauricio Castaneda Caballero

Vice President, Divisional

Mr. Luis Alberto Palacios Aragon

Vice President, Divisional

Mr. Jose Minski

Director

Mr. Alejandro Weinstein

Director

Ownership

Institution Holdings

Credicorp Capital Asset Management S.A. AGF

256,406 (0.227%)

Moneda S.A. Administradora General de Fondos.

101,573 (0.090%)

Arrow Capital Management Inc

46,031 (0.041%)

Susquehanna International Group, LLP

36,385 (0.032%)

UBS Group AG

31,028 (0.028%)

Geode Capital Management, LLC

25,386 (0.023%)

Fidelity Management & Research Company LLC

25,386 (0.023%)

SSGA Funds Management Inc

12,363 (0.011%)

State Street Corporation

12,238 (0.011%)

Activest Wealth Management

10,000 (0.009%)

Funds Holdings

Fidelity Nasdaq Composite Index Fund

28,938 (0.026%)

Details

Overview

Company Info

Key Ratios

Income

Balance Sheet

Cash Flow

Bubble

Make Smart Investment Choices